Gene therapy targeting aging - Rejuvenate Bio
Latest Information Update: 22 Mar 2024
At a glance
- Originator Rejuvenate Bio
- Class Gene therapies
- Mechanism of Action Gene transference; Transcription factor replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Sarcopenia